Principal Investigator
Alan Libardi Dal Pra
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20241175
Clinical Trial Summary
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
+1 (305) 2439731